Trials / Completed
CompletedNCT07032337
Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder
Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder: A Target Trial Emulation Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,985 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Newly diagnosed NMOSD patients
Detailed description
From 2011 to 2022, newly diagnosed NMOSD patients who had not previously claimed NMOSD. Exclusion criteria were history of cancer or had used ISTs (excluding steroids) prior to the NMOSD diagnosis.
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2025-06-23
- Last updated
- 2025-06-23
Source: ClinicalTrials.gov record NCT07032337. Inclusion in this directory is not an endorsement.